Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1191 of 5804
-
New weekly injection shows promise for weight loss in early trial
Disease control OngoingThis study tests how well different doses of the medicine NNC0662-0419 help people living with overweight or obesity. The purpose of the study is to find out if NNC0662-0419 is safe and effective for treating people living with overweight or obesity. There are 2 study treatments …
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Custom immune attack: new gene therapy targets Hard-to-Treat cancers
Disease control Not yet recruitingThis is a single center, single arm, open-label, dose escalation, phase 1 study to evaluate the safety, tolerability and preliminary efficacy of KXV01 TCR Lentinvivo for patients with advanced solid tumors.
Phase: PHASE1 • Sponsor: TCRx Therapeutics Co.Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New drug cocktail aims to tackle Hard-to-Treat prostate cancer
Disease control Recruiting nowThe main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer agents for treatment of metastatic prostate cancer.
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New hope for breast cancer survivors: laser and gel may ease vaginal atrophy without hormones
Symptom relief Not yet recruitingThe genito-urinary syndrome of menopause severely affects patients with a history of gynecological cancer, especially those diagnosed with breast cancer. At the present time, we do not have solid scientific evidence on treatments that can be effective and safe to address this pat…
Phase: NA • Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz • Aim: Symptom relief
Last updated Jun 26, 2026 19:20 UTC
-
New scan aims to spot breast cancer more accurately
Diagnosis Not yet recruitingBreast cancer is the most common type of cancer in Norwegian women, with 4,224 new cases in 2022. More precise diagnosis are expected to result in more accurate assessment of treatment effect, and to contribute to both providing better treatment and reducing overtreatment. Fibrob…
Phase: NA • Sponsor: St. Olavs Hospital • Aim: Diagnosis
Last updated Jun 26, 2026 17:28 UTC
-
AI on your phone could stop diabetic foot ulcers before they start
Prevention Not yet recruitingFor people with diabetes who are at risk of foot ulcers, this study compares three digital foot care strategies (with different levels of intensity) to see which one is more effective at preventing ulcers and easier to use.
Phase: NA • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
New radiation regimen cuts treatment time for early glottic cancer
Disease control Not yet recruitingEarly-stage glottic carcinoma (T1-T2N0M0) is typically managed with either transoral laser microsurgery or definitive radiotherapy, both providing excellent local control rates and voice preservation outcomes. Radiotherapy remains a widely adopted non-invasive option, particularl…
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New antibody treatment could tame rare brain disease Flare-Ups
Disease control Not yet recruitingThis study aims to evaluate the efficacy and safety of different monoclonal antibody in the acute phase of neuromyelitis optica spectrum disorder (MAAP-NMO). It will also examine immune-related biomarkers and their relationship with treatment response to provide evidence for opti…
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 26, 2026 19:21 UTC
-
New pill RAP-103 aims to clear psoriasis in 8 weeks
Disease control Recruiting nowRandomized, controlled trial, Proof of Concept, Phase 2 aimed to evaluate the effect of CBP-0276 in dose of 200mg twice dose a day, or placebo administrated for 36 weeks to improve Psoriasis Area and Severity Index (PASI)75 or static Physician's Global Assessment (sPGA) score of …
Phase: PHASE2 • Sponsor: Clarent Biopharma, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Fewer days of radiation may control brain tumors just as well
Disease control Not yet recruitingThe goal of this prospective, multi-center, randomized double-arm clinical trial is to demonstrate a benefit in term of local control of a shorter spread of hypofractionated stereotactic radiotherapy at D1-2-3 vs D1-3-5, in the treatment of "radioresistant" Brain Metastases (BM).…
Phase: PHASE3 • Sponsor: Centre Paul Strauss • Aim: Disease control
Last updated Jun 26, 2026 16:49 UTC
-
Laser zaps brain tumor, then chemo moves in: new combo trial opens
Disease control Recruiting nowThis is a phase 1 study evaluating the safety and feasibility of laser interstitial thermal therapy (LITT) followed by lomustine (CCNU) for recurrent glioblastoma in adults. The primary aim is to evaluate the safety of the combination of LITT plus lomustine based on the assessmen…
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Second chance: drug combo retested for tough colorectal cancer
Disease control Not yet recruitingThis is an open-label, unicentre, single-arm Phase 2 study of encorafenib and cetuximab as rechallenge treatment in patients with BRAF V600E-mutant metastatic colorectal cancer after previous therapy with BRAF inhibitors-based combinations. The study aims to evaluate the antitum…
Phase: PHASE2 • Sponsor: Vall d'Hebron Institute of Oncology • Aim: Disease control
Last updated Jun 26, 2026 18:05 UTC
-
Can a common supplement reverse stomach cancer risk?
Disease control Not yet recruitingThe goal of this clinical trial is to investigate the efficacy of Berberine in treating gastric intestinal metaplasia in Helicobacter pylori-negative adults. It will also learn about the safety of Berberine. The main questions it aims to answer are: Does Berberine promote the re…
Phase: PHASE4 • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jun 26, 2026 13:51 UTC
-
New eczema foam shows promise in Late-Stage trial
Disease control Not yet recruitingTo investigate the superiority of 1% OPA-15406 foam to the vehicle in adult patients with atopic dermatitis (AD).
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 16:58 UTC
-
AI and a simple blood test could spot Alzheimer's years early
Knowledge-focused Recruiting nowThis study focuses on improving early detection of Alzheimer's disease (AD) in patients with subjective cognitive decline (SCD), a preclinical stage of cognitive impairment, in the context of emerging disease-modifying therapies (DMTs). Current biomarkers, such as brain MRI, PET …
Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Stanford scientists zap brains to unlock schizophrenia secrets
Knowledge-focused Recruiting nowSchizophrenia - marked by delusions, hallucinations, and cognitive deficits - causes the most disability of any mental health condition, but existing treatments have significant side effect burden and are often ineffective. Disordered neural activity in the hippocampus likely con…
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Dancing away danger: Music-Based exercise may cut falls in seniors with diabetes
Disease control Recruiting nowThe DIACTIVE study is a randomized controlled trial with a 5- year follow-up designed to evaluate the impact of comprehensive screening and multicomponent interventions on fall prevention, bone health, nerve function and cardiovascular outcomes in people with diabetes aged 65 yea…
Phase: NA • Sponsor: Aalborg University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Could a softer sedation and early exercise keep ICU patients stronger?
Disease control CompletedThis single-center, prospective, randomized controlled trial aims to evaluate whether an eCASH concept-based analgesia and sedation strategy combined with early goal-directed mobilization can reduce the incidence of intensive care unit-acquired weakness (ICU-AW) in mechanically v…
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a plastic bottle help people with Parkinson's breathe easier and stay steady?
Disease control Recruiting nowParkinson's disease (PD) is a progressive neurodegenerative disorder characterized by rigidity, tremor, postural instability, bradykinesia, and autonomic dysfunction. It is a common movement disorder worldwide. Motor impairments in PD patients are not limited to the muscles of th…
Sponsor: Marmara University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can robot legs help Non-Walking kids join in at school?
Symptom relief ENROLLING_BY_INVITATIONRobot-assisted walking offers children who are unable to walk new avenues for participation in their communities in addition to health benefits. Disappointingly, most children cannot access this impactful technology. One of every 1000 children cannot walk due to cerebral palsy,1 …
Phase: NA • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC